Response to immunosuppressive therapy (IST) in younger patients with myelodysplastic syndrome (MDS) has been linked to a T-cell-dominant autoimmune process that impairs hematopoiesis. Analysis of the age-adjusted CD4:CD8 ratio in 76 MDS patients compared with 54 healthy controls showed that inadequate CD4 þ , rather than expansion of CD8 þ T cells, was associated with a lower ratio in a group that included both lower and higher risk MDS patients defined by the International Prognostic Scoring System. In younger MDS patients, naive and memory phenotypes defined by CD45RA and CD62L display showed depletion of naive CD4 þ and CD8 þ T cells, suggesting a possible relationship to IST responsiveness. To determine the correlation between T-cell subset distribution, T-cell turnover and autoimmunity, a cohort of 20 patients were studied before and after IST. The CD4:CD8 ratio correlated inversely with the proliferative T-cell index before treatment in IST-responsive patients, suggesting that proliferation may be linked to accelerated CD4 þ T-cell turnover and hematopoietic failure. Our data show seminal findings that both CD4 þ and CD8 þ T-cell subsets are dysregulated in MDS. Association between these T-cell defects and response to IST suggests that aberrant T-cell homeostasis and chronic activation are critical determinants influencing autoimmune hematopoietic suppression in younger patients.
Introduction
In MDS patients of younger age, a higher frequency of clinical responsiveness to immunosuppressive therapy (IST) with antithymocyte globulin (ATG) and/or cyclosporine A suggests that unique immune pathobiology contributes to the refractory cytopenias observed in such patients. Factors associated with response to IST included HLA-DR-15 genotype, age, o5% marrow blasts, low risk for leukemia transformation and in some studies hypocellularity.
1,2 Among these factors, younger age is the most consistently linked clinical feature associated with IST responsiveness in both patients with aplastic anemia and in patients with MDS. 2, 3 A model of immune pathogenesis first proposed by Molldrem et al. 4 suggests that unique or overexpressed antigens stimulate CD8 þ T cells, induce T-cell receptor repertoire contraction through expansion of memory cells, and repress hematopoiesis through cross-reactive antigens expressed on normal bone marrow progenitors. In the subset of patients responsive to immunosuppression, effects of the selfreactive T-cell populations are thought to be eliminated by the immunosuppressive actions of these drugs. 4, 5 We investigated the clinical features associated with reduced repertoire diversity in MDS patients and found that the expansion of clonal T cells was not selectively associated with younger age or transfusion history, and occurred independent of risk for leukemia progression based on a standard criteria, namely, the International Prognostic Scoring System. On the basis of these data, we concluded that the contraction of T-cell receptor repertoire may be widespread in MDS, and that additional factors present in younger patients may impart IST responsiveness. In this study, we present important new data showing that aberrant CD4 þ and CD8 þ T-cell homeostasis in younger MDS patients may represent an autoimmune signature for clinical responsiveness to IST. A high proliferative index in naive T cells suggests that dysregulation is linked to the interleukin (IL)-2 receptor b and g common family cytokines (IL-2Rbg c ) IL-7, IL-15 and IL-21.
Materials and methods

Patients and healthy controls
Seventy-six MDS patients were analyzed in total. The untreated MDS patients (n ¼ 47) were recruited from the Malignant Hematology clinic at the H Lee Moffitt Cancer Center and Research Institute. Diagnoses were confirmed by pathology and classified in accordance with the World Health Organization criteria. After obtaining written informed consent, 40 ml of peripheral blood was collected in heparinized tubes from each patient. Samples from 29 patients were obtained in collaboration with Dr Elaine Sloand of the National Heart, Lung and Blood Institute (NHLBI), Bethesda, MD, USA. Twenty patients had been treated with ATG alone or ATG plus cyclosporine, and samples were analyzed before and after the therapy. For use as controls, buffy coats from healthy blood donors were obtained from the Southwest Florida Blood Services in St. Petersburg, FL, USA. Peripheral blood mononuclear cells were isolated from MDS patients and healthy donors by Ficoll-Hypaque (Amersham Pharmacia Biotech, Piscataway, NJ, USA) gradient centrifugation, as described earlier, and frozen in liquid nitrogen. 6 
Detection of naive and memory T-cell subpopulations
Cryopreserved peripheral blood mononuclear cells were thawed and incubated with antibodies to distinguish naive and memory T cells. CD4 and CD8 T-cell subtypes were detected after surface staining with anti-CD3-phycoerythrin (PE) Cy7, anti-CD45RA-FITC, anti-CD62L-APC and either anti-CD4-or CD8-APC Cy7, which were all obtained from BD Biosciences, San Jose, CA USA. Naive and memory T-cell populations were distinguished by CD45RA and CD62L expression, as described earlier by flow cytometry. 7, 8 Exclusion of 4 0 ,6-diamindigo-Zphenylinodole (DAPI) was used to distinguish cell viability. Results of flow cytometry were analyzed on a LSRII Benchtop analyzer (BD Bioscience).
Flow cytometry to detect proliferation
Cell proliferation was measured by Ki67 nuclear antigen expression. Ki67 is expressed by cells in late G1, S, G2 and M phase of the cell cycle. 9, 10 In earlier studies, Ki67 staining was positively correlated with deuterated glucose labeling of dividing cells in vivo. 10 To determine the percentage of proliferating cells within specific lymphocyte subsets, a gate was used to define CD3 þ T cells that were CD4 þ or CD8 þ and stained with antiKi67 þ antibodies within the lymphocyte gate (R1, in Figure 1 ) to determine the expression in naive and memory T-cell subsets based on CD45RA and CD62L surface markers. Anti-Ki67-PE was used to stain the intracellular nuclear antigen after subsequent fixation and permeabilization (BD Biosciences Fix and Perm kit, San Jose, CA, USA) as recommended by the manufacturer.
Statistical analysis
The statistical methods used included linear regression, the Wilcoxon rank sum test and the Wilcoxon signed rank test (in the instances of paired data). When adjustment for multiple testing was necessary, the Holm step-down method was used. A two-sided Po0.05 was considered as statistically significant. The specific statistical tests that were used in each experiment are noted in the figure and table legends. Reduced CD4:CD8 ratio in MDS patients CD4 þ T cells are normally present in the peripheral blood lymphocyte pool at 2-4 times greater than that of CD8 þ T cells, ). An interaction term between age and disease status was not statistically significant (P-value ¼ 0.71) and was dropped from the final model. Disease status was significantly associated with log(CD4:CD8) (P-valueo0.0001) while adjusting for age. Regression analyses were also performed separately for CD4 (b) and CD8 (c) in a log scale. While adjusting for age, %CD4 was significantly lower in MDS cases compared with controls (P-value o0.0001) but there was no difference in % CD8 (P-value ¼ 0.42). No interaction between age and disease status was observed in either model (P ¼ 0.31 and P ¼ 0.13 for CD4 and CD8, respectively). and diminished CD4:CD8 ratio has been shown earlier to correlate with poor survival outcome in MDS. [11] [12] [13] [14] [15] [16] Similar to earlier reports, we found that the CD4:CD8 ratio was reduced in MDS patients compared with the healthy controls after adjusting for age (P-value o0.0001) (Figure 1a ). To assess whether the case-control difference in the CD4:CD8 ratio was due to differences in CD4, CD8 or both, percentages of each cell type were individually compared between cases and controls after adjusting for age. This analysis showed that the percentage of CD4 cells was reduced in the peripheral lymphocyte pool among MDS cases as compared with controls ( Figure 1b , P-value o0.0001), although there was no difference in the percentage of CD8 cells (Figure 1c , P-value ¼ 0.42). There was no statistically significant interaction between age and reduction in CD4:CD8 ratio in this analysis. These results suggest that changes in the CD4 þ lymphocyte pool may be responsible for the diminished CD4:CD8 ratio with well-described significance in MDS. [11] [12] [13] [14] [15] [16] T-cell subset distribution is defective in CD4 þ and CD8 þ T cells in MDS patients
Results
Clinical characteristics of MDS patients
Since we found that CD4 þ T cells are diminished in MDS patients, and CD8 þ T cells have been shown to display T-cell receptor repertoire restriction, we examined the phenotype of both CD4 þ and CD8 þ T-cell populations in the same group of MDS cases and controls. Isoforms of the tyrosine phosphatase CD45RA, CD45RO, and CD45RB, along with L-selectin (CD62L), have been used to distinguish naive from memory T cells. 8, [17] [18] [19] We used multiple-color flow staining to distinguish the T-cell subpopulations. An illustration of these markers is shown in Supplementary  Figure 1 for a healthy control donor. We compared the proportion of circulating naive and memory CD4 þ and CD8 þ T-cell subpopulations in MDS patients (n ¼ 47) and healthy control donors, individually age-matched to MDS patients within 4 years (n ¼ 47). Data in Figure 2 show that the percentages of naive CD4 þ and CD8 þ T cells are lower in MDS. In the T-cell pool, both CD4 þ and CD8 þ naive cells were under-represented in cases compared with controls (Po0.0001 for both populations). In addition to reduced naive cells, the memory CD4 þ and CD8 þ subpopulations displaying a CD45RAÀ/CD62LÀ (effector memory) and CD45RA þ /CD62LÀ (terminal effector memory) phenotype were increased in cases compared with controls.
As the proportion of naive and memory T-cell distributions change with age due to the reduction in thymic function, the age-related differences among the MDS cases, which ranged from 19 to 82 years old (n ¼ 47), was compared with control with results shown in Figure 3 . Furthermore, T-cell homeostatic mechanisms have been reported to differ among CD4 and CD8 populations with age. [20] [21] [22] [23] Among these cases, positive correlations were observed between age and both % CD62L positive naive cells and central memory CD4 þ T cells, although the former association was not statistically significant (naive, slope ¼ 0.186, P ¼ 0.14; central memory, slope ¼ 0.685, P ¼ 0.001). Furthermore, the proportions of CD62LÀ CD4 þ T-cell populations, including effector memory and terminal effector memory T cells, were greater in younger MDS patients (slope ¼ À0.433, P ¼ 0.128 and slope ¼ À0.364, P ¼ 0.128, respectively). Similar patterns with age were observed for naive, central memory, effector memory and terminal effector memory CD8 þ T cells, although the associations were weaker than those observed for CD4 þ T cells, and only the reduction in central memory cells in younger patients was statistically significant (Figure 3b , slope ¼ À0.249, P ¼ 0.022). These agerelated changes in T-cell phenotype were distinctly different from those observed in CD4 þ or CD8 þ T cells from controls, as shown in Figure 3 , that ranged in age from 19 to 81 years old (n ¼ 54). Although there was a slight tendency for CD4 þ naive cells to decrease with age, this trend was not statistically significant (slope ¼ À0.11, P ¼ 1.0), and central, effector and terminal effector memory CD4 þ T-cell subpopulations did not change with age within the CD4 þ subset (Figure 3c ). In these healthy control donors, a dramatic age-related change in T-cell homeostasis occurred within the CD8 þ T-cell compartment. The percentage of naive CD8 þ T cells decreased 0.61% with each year of age (P ¼ o0.0001); whereas, conversion of the peripheral pool to terminal effector memory cells was positively associated with age (0.567% increase with each year of age, P ¼ 0.001), as shown in Figure 3d (left panel). In summary, results show that there is a particular skewing of CD4 þ and CD8 þ T cells toward a CD62L-phenotype with reduction in naive cells in younger MDS patients.
Aberrant homeostatic T-cell regulation before to treatment in patients responsive to IST Diminished naive T cells may result from accelerated turnover characterized by increased cell death or increased conversion of naive cells into memory cells, similar to abnormalities observed Figure 2 Naive and memory phenotype analysis in myelodysplastic syndrome (MDS) patients and healthy controls. Case-control differences between T-cell subpopulations were compared in 47 MDS patients and 47 healthy controls using the Wilcoxon signed rank test adjusting for multiple testing using the Holm's step-down method. P-values for the case-control differences are shown at the top of each panel.
Altered naive and memory CD4 þ T-cell homeostasis JX Zou et al in association with other autoimmune syndromes. [24] [25] [26] [27] As younger age in MDS represents an important characteristic related to IST response, the CD4 þ and CD8 þ naive and memory cell populations and the CD4:CD8 ratio were compared among eight IST responders and fifteen nonresponders (ages ranged from 19 to 72 years old with a mean Figure 3 Age-dependent changes in naive and memory T-cell subpopulations in myelodysplastic syndrome (MDS) patients. Using CD45RA and CD62L staining, naive CD62 L þ /CD45RA þ (naive), central memory CD62L þ /CD45RA-(central), effector memory CD62LÀ/CD45RA þ (effector) and terminal effector memory CD62LÀ/CD45RA þ (terminal) were determined in 47 MDS patients (black circles, dotted line) and plotted against age in years. The frequencies of CD4 þ and CD8 þ T-cell subpopulations are shown in MDS patients (a) and controls (b). Associations with age were evaluated using simple linear regression, adjusting for multiple testing with the Holm's step-down method. Lines indicate data trends in MDS cases and controls, and the slopes with the corresponding P-values are presented (P-values o0.05 are considered statistically significant).
Altered naive and memory CD4 þ T-cell homeostasis JX Zou et al age of 46 and 62 years among responders and non-responders, respectively) to gain a better understanding of how altered T-cell homeostasis affects bone marrow suppression among the younger cases. To understand the relationship between T-cell turnover and IST response, we also determined the expression of Ki67, a nuclear proliferation-associated antigen, as an indicator of proliferation in both the CD4 þ and CD8 þ T cells. Patients were treated with either equine ATG or ATG plus cyclosporine A, and hematological response was assessed using the International Working Group criteria with clinical results reported elsewhere. 28, 29 First, immune parameters were compared before treatment between patients that showed hematological response (complete response and partial response) and those showing no clinical hematological improvement to this therapy. We found that the CD4:CD8 ratio before treatment was statistically significantly lower in the IST responders compared with non-responders ( Figure 4a ) (P ¼ 0.0003). Interestingly, we found that the pre-treatment % of Ki67-positive cells in both the CD4 þ and CD8 þ subpopulations was significantly greater in MDS patients showing a response to IST compared with patients who did not respond (P ¼ 0.0038 and P ¼ 0.0005, respectively, Figure 4b ). In Figures 4c and d , we show inverse correlations between the percentage of Ki67 þ /CD4 þ and Ki67 þ /CD8 þ T cells and the CD4:CD8 ratio, which was statistically significant for the CD4 þ population (P ¼ 0.0123 for CD4 þ and P ¼ 0.0619 for CD8 þ cells while adjusting for age). These results suggest that cells within both of these compartments are actively cycling when the ratio is diminished in MDS patients.
Reconstitution of T-cell homeostasis is associated with recovery of bone marrow hematopoiesis after therapy
Next, we compared the changes in key immune parameters before and after IST in association with clinical hematological response. The proliferative index is dramatically reduced after treatment specifically in the IST responsive patients as compared with the non-responsive patients in both the CD4 þ and CD8 þ T cells as shown by Ki67 expression. To determine whether the changes in proliferation affected all of the CD4 þ and CD8 þ subpopulations, individual analyses were performed on naive and memory cells defined by % Ki67 in association with CD45RA and CD62L staining using the gating strategy shown in Figure 5a . After treatment, a reduction in Ki67 expression was observed in naive and all memory subpopulations after IST in patients with a hematological response compared with changes in the non-responders (Figure 5b , Po0.05 for all tests). These results strongly suggest that proliferation may be coupled to accelerated T-cell depletion and altered T-cell homeostasis, which eventually leads to a reduction in naive cells. Consistent with this idea, patients showing a hematological response to IST displayed an increase in naive CD4 þ and CD8 þ T cells after treatment compared with non-responders ( Figure 5c ) (P ¼ 0.001 and P ¼ 0.0001, respectively). In summary, results show that proliferation in T cells is higher and the CD4:CD8 ratio is lower before treatment in younger IST responsive patients. Furthermore, results also show that hematological response is associated with reconstitution of T-cell homeostasis and reduction in homeostatic proliferation. Altered naive and memory CD4 þ T-cell homeostasis JX Zou et al
Discussion
Myelodysplastic syndromes are acquired clonal disorders of hematopoietic progenitors that are characterized by peripheral cytopenias and cytologic dysplasias. 30 There is a strong association between bone marrow failure and autoimmunity that transects classical autoimmune processes such as aplastic anemia, rheumatoid arthritis, Felty's syndrome and large granular lymphocyte leukemia. [31] [32] [33] Similar to these quintessential autoimmune bone marrow failure syndromes, hematopoietic suppression by a T-cell dominant autoimmune process and IST responsiveness has been proposed in younger MDS patients. In MDS cases in which hematological improvement is observed after IST, the response can be durable leading to improved longterm survival. 1, 34, 35 Despite a clear therapeutic benefit and a basic understanding of immune pathology, IST is rarely offered to MDS patients as a treatment option in the United States because of an uncertainty about the appropriate selection of patients for such therapy. 36 There is an underlying concern that inappropriate use of IST may negatively affect the risk for leukemia progression, which occurs in 30-40% of MDS cases. This is of particular concern in younger patients that may benefit from allogeneic stem cell transplantation. 37 The identification of immunological factors in addition to younger age to guide appropriate selection of patients for IST based on immune pathobiology is critical to the optimization of MDS treatment.
As little is known about age as a modifier of immunity in MDS, the current study was conducted to determine whether T-cell homeostasis and function is normal and age-appropriate in MDS patients. Unlike most earlier reported findings in CD8 þ T cells, we found that contraction of naive and central memory cells and accumulation of effector and terminal Figure 5 continued Altered naive and memory CD4 þ T-cell homeostasis JX Zou et al effector-memory cells were also pronounced within the CD4 þ T-cell compartment in younger MDS patients, and that reduction in the CD4:CD8 ratio was driven by an age-independent decrease in CD4 þ T cells. 4, 14, 38, 39 To discern how these agerelated abnormalities defined in the case-control study may affect bone marrow suppression, we studied T-cell immunity in 20 MDS patients before and after treatment with ATG with or without cyclosporine A. Results presented here strongly suggest that reduced CD4 þ T cells not only drive the aberrant CD4:CD8 ratio in a diverse group of MDS patients, but also robustly associated with IST responsiveness in younger patients. In addition to reduced CD4 þ T cells, altered naive and memory subset distribution was found in CD4 þ T-cell and CD8 þ cells.
In younger MDS patients, fragility of the CD4 þ naive T-cell compartment is strikingly different than changes associated with a normal aging process where CD4 þ naive cells remain constant, as shown in Figure 3 . In healthy controls, our results are consistent with previous studies showing that regulation of CD4 þ and CD8 þ homeostasis occurs through distinct mechanisms during the aging process. CD4 þ T cells from patients are clearly more vulnerable to depletion compared with controls. 20 There are several examples, including rheumatoid arthritis, infection with human immunodeficiency virus-1 and individuals with repeated pathogen exposure, where peripheral CD4 þ naive T cells are diminished and the CD4:CD8 ratio shifted in association with chronic activation. 9, 40, 41 Therefore, these results suggest that CD4 þ T cells in addition to CD8 þ T cells have been activated in vivo.
Reduction in naive cells in MDS may be mediated by either increased apoptotic sensitivity or increased rate of phenotype conversion to memory cells. 40, 42 A mechanism of increased sensitivity to apoptosis is consistent with earlier findings that hypocellularity, in some studies, is associated with clinical responsiveness to IST. 1,2 Greater susceptibility to Fas-mediated apoptosis and higher levels of tumor necrosis factor a have also been consistently linked to bone marrow failure in not only MDS but also in large granular lymphocyte leukemia. [43] [44] [45] [46] [47] [48] A higher proliferative index, especially affecting naive cells, in younger IST-responsive MDS cases indicates that T cells in these patients have been exposed to conditions which promote nonantigen-specific proliferation (i.e., homeostatic proliferation) driven by the IL-2Rbg c family of cytokines IL-7, IL-15 and/or IL-21, which are associated with risk for autoimmunity in many situations. [49] [50] [51] An increase in T-cell homeostatic proliferation in response to the IL-2Rbg c leads to the indiscriminate expansion of both nonthymic-depleted self-reactive T cells and antigen-specific T cells. An increase in homeostatic proliferation alone, however, generally fails to induce autoimmunity. It is the combination of homeostatic proliferation and defects in one or more additional factor(s) circumventing mechanisms of peripheral tolerance that leads ultimately to autoimmunity in this setting. 24 It is possible that loss of the CD4 þ T cells in MDS may represent depletion or functional inactivation of a specific subset of CD4 þ T cells, namely, regulatory T cells (Tregs), which are important for peripheral tolerance and prevention of an autoimmune process. [52] [53] [54] [55] Tregs express high levels of CD25 (IL-2Ra) with low (dim) expression of IL-7Ra (CD127), and suppress CD4 þ and CD8 þ responses to not only T-cell receptor stimulation but also homeostatic proliferation. 24, [56] [57] [58] Tregs can develop in the thymus (natural, nTregs) or they can be expanded in the periphery (inducible Tregs, iTregs). 59 Tregs are characterized by Figure 5 Change in T-cell homeostasis after therapy in immunosuppressive therapy responsive and non-responsive patients. After labeling T-cell surface markers, the first gate was given to lymphocytes (as shown in Figure 1 , R1, a). T cells were identified by anti-CD3-antibody staining (data not shown, b); gates were then set to distinguish CD8-(CD4 þ ) and CD8 þ T cells populations (data not shown, (c)). (a) Using expression patterns of CD62L (x-axis) and CD45RA (y-axis), the following populations were distinguished in CD4 þ and CD8 þ T cells: naive CD62L þ /CD45RA þ (R4), central memory CD62L þ /CD45RA-(R5), effector memory CD62LÀ/CD45RA-(R6) and terminal effector memory CD62LÀ/CD45RA þ (R7). The % Ki67 positive cells and isotype control-PE were concomitantly determined on R4-R7 gated populations as shown. Results are shown for the percentage of each subpopulation that expressed Ki67 was determined in individual gates before and after treatment in one exemplary MDS patient. (b) The % Ki67 positive CD4 þ (solid lines) and CD8 þ (dashed lines) were determined in naive CD45RA þ /CD62L þ (circle), central memory (CD45RA þ /CD62LÀ) (square), effector memory (triangle) and terminal effector memory (hashed mark). For each of these eight cell populations, changes in % Ki67 from before treatment (pre-TX) to after treatment (post-TX) were compared between responders (open circles) and non-responders (open triangles) using the Wilcoxon rank sum test, adjusting for multiple testing using the Holm's step-down method (Po0.05 for all eight comparisons). (c) The pre-TX versus post-TX changes in percentage of naive CD62L þ /CD45RA þ were also compared between patients that displayed a clinical response (responders) and patients that failed to respond to immunosuppression (non-responders) using the Wilcoxon rank sum test, adjusting for multiple testing using the Holm's step-down method.
the expression of the FOXP3 transcription factor with greater expression of the negative co-stimulatory molecule cytotoxic T lymphocyte-associated antigen 4. 60 The number of Tregs in the peripheral blood of MDS patients has been shown to positively correlate with risk for disease progression. Further investigation is needed to determine whether the number and/or function of Tregs is lower in IST-responsive patients compared with healthy controls with age adjustment. The latter is important as Treg number and/or function may vary with age. 21, 61 Furthermore, elevated levels of IL-21 have recently been shown to suppress Treg function without affecting cell numbers. In addition to Treg reduction, excessive IL-21 62 or an inflammatory microenvironment independently acts as catalyzing factors for homeostatic proliferation-associated autoimmunity. 24 Regardless of the cellular mechanisms that govern the proliferation and turnover in the T-cell compartment, the association between the T-cell abnormalities reported in this study and response to IST provides a strong rationale implicating aberrant T-cell homeostasis as a critical determinant of autoimmunity in MDS, which may have positive predictive power for response to IST. In summary, our findings are consistent with a model that IST blocks the proliferative signal that is associated with depletion of CD4 þ T cells and expansion of autoreactive CD8 þ T cells, and restores T-cell homeostasis of the CD4 þ and CD8 þ T-cell compartment. The presence of altered T-cell homeostasis may represent a marker that is predictive for IST responsiveness.
